Skip to main content
. Author manuscript; available in PMC: 2023 Feb 17.
Published in final edited form as: Semin Arthritis Rheum. 2022 Oct 17;57:152106. doi: 10.1016/j.semarthrit.2022.152106

Table 5.

Immunosuppressant Use and PJP Prophylaxis.

Immunosuppressant Odds Ratio*(95% CI) p value
Renal transplant conditioning regimens** 7.93 (4.53 – 13.87) < 0.001
Calcineurin or mTOR inhibitors 5.12 (3.39 – 7.72) < 0.001
Mycophenolate mofetil 2.04 (1.46 – 2.86) < 0.001
Cyclophosphamide 1.95 (1.31 – 2.89) < 0.001
Rituximab 1.33 (0.79 – 2.24) 0.28
*

Odds ratio calculated based on patients on each respective medication compared to patients not on each medication.

**

Renal transplant conditioning regimens included thymoglobulin, alemtuzumab, or basiliximab.